Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Fampridine 10 mg prolonged-release tablet (per os)
Placebo (tablets per os)
Locations
9
France
Neurology Department, CHU d'Angers
Angers, France
Genetics Department, CHU de Bordeaux
Bordeaux, France
Neurology and Gentics Department, CHU de Dijon
Dijon, France
Neurology Department, Hôpital Pierre Wertheimer Hospital
Lyon, France
Neurology Department, Gui De Chauliac Hospital
Montpellier, France
Genetics Department, Pitié-Salpêtrière University Hospital
Paris, France
Start Date
October 21, 2025
Primary Completion Date
May 21, 2027
Completion Date
May 21, 2027
Last Updated
December 10, 2025
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions